Bahrami S, Ansari B, Norouzi-Barough L, Bagherpour B, Khorvash F, Shirani K
Eur J Med Res. 2025; 30(1):131.
PMID: 39994747
PMC: 11849160.
DOI: 10.1186/s40001-025-02378-w.
Cotton S, Subramanian A, Hughes T, Huang Y, Sierra C, Pearce A
Vaccine. 2024; 42(10):2655-2660.
PMID: 38490824
PMC: 11182488.
DOI: 10.1016/j.vaccine.2024.02.036.
Burhan E, Mubarak F, Adilah S, Sari C, Ismail E, Astuti P
Front Med (Lausanne). 2023; 10:1190148.
PMID: 37457562
PMC: 10339801.
DOI: 10.3389/fmed.2023.1190148.
Li Y, Zhu N, Cui X, Lin Y, Li X
Front Cell Infect Microbiol. 2023; 13:1178590.
PMID: 37207192
PMC: 10189063.
DOI: 10.3389/fcimb.2023.1178590.
Nasoufidou A, Kavelidou M, Griva T, Melikidou E, Maskalidis C, Machaira K
Front Med (Lausanne). 2023; 10:1103701.
PMID: 37153106
PMC: 10157639.
DOI: 10.3389/fmed.2023.1103701.
Systematic review and meta-analysis of the clinical outcomes of ACEI/ARB in East-Asian patients with COVID-19.
Huang N, Yuan Q, Fang F, Yan B, Sanderson J
PLoS One. 2023; 18(1):e0280280.
PMID: 36634085
PMC: 9836310.
DOI: 10.1371/journal.pone.0280280.
Drug-Disease Severity and Target-Disease Severity Interaction Networks in COVID-19 Patients.
Schoning V, Hammann F
Pharmaceutics. 2022; 14(9).
PMID: 36145576
PMC: 9504398.
DOI: 10.3390/pharmaceutics14091828.
Drugs acting on the renin-angiotensin-aldosterone system (RAAS) and deaths of COVID-19 patients: a systematic review and meta-analysis of observational studies.
Sharma R, Kumar A, Majeed J, Thakur A, Aggarwal G
Egypt Heart J. 2022; 74(1):64.
PMID: 36068392
PMC: 9448845.
DOI: 10.1186/s43044-022-00303-8.
Chronic use of renin-angiotensin-aldosterone inhibitors in hypertensive COVID-19 patients: Results from a Spanish registry and meta-analysis.
Aparisi A, Catala P, Amat-Santos I, Marcos-Mangas M, Lopez-Otero D, Veras C
Med Clin (Engl Ed). 2022; 158(7):315-323.
PMID: 35531305
PMC: 9063316.
DOI: 10.1016/j.medcle.2021.04.026.
The Effects of Different Classes of Antihypertensive Drugs on Patients with COVID-19 and Hypertension: A Mini-Review.
Nozari F, Hamidizadeh N
Int J Hypertens. 2022; 2022:5937802.
PMID: 35075396
PMC: 8783136.
DOI: 10.1155/2022/5937802.
Meta-analysis of the association between angiotensin pathway inhibitors and COVID-19 severity and mortality.
Fernando M, Drovandi A, Golledge J
Syst Rev. 2021; 10(1):243.
PMID: 34488897
PMC: 8421238.
DOI: 10.1186/s13643-021-01802-6.
Safety and Efficacy of Renin-Angiotensin-Aldosterone System Inhibitors in COVID-19 Population.
Sattar Y, Mukuntharaj P, Zghouzi M, Suleiman A, Attique H, Ullah W
High Blood Press Cardiovasc Prev. 2021; 28(4):405-416.
PMID: 34181203
PMC: 8237039.
DOI: 10.1007/s40292-021-00462-w.
Association of ACEi/ARB Use and Clinical Outcomes of COVID-19 Patients With Hypertension.
Ma J, Shi X, Yu J, Lv F, Wu J, Sheng X
Front Cardiovasc Med. 2021; 8:577398.
PMID: 34136537
PMC: 8202940.
DOI: 10.3389/fcvm.2021.577398.
Comparison of renin-angiotensin-aldosterone system inhibitors with other antihypertensives in association with coronavirus disease-19 clinical outcomes.
Bezabih Y, Bezabih A, Alamneh E, Peterson G, Bezabhe W
BMC Infect Dis. 2021; 21(1):527.
PMID: 34090358
PMC: 8178664.
DOI: 10.1186/s12879-021-06088-6.
Chronic use of renin-angiotensin-aldosterone inhibitors in hypertensive COVID-19 patients: Results from a Spanish registry and meta-analysis.
Aparisi A, Catala P, Amat-Santos I, Marcos-Mangas M, Lopez-Otero D, Veras C
Med Clin (Barc). 2021; 158(7):315-323.
PMID: 34088524
PMC: 8101788.
DOI: 10.1016/j.medcli.2021.04.005.
The therapeutic effect and safety of the drugs for COVID-19: A systematic review and meta-analysis.
Qiu R, Li J, Xiao Y, Gao Z, Weng Y, Zhang Q
Medicine (Baltimore). 2021; 100(16):e25532.
PMID: 33879694
PMC: 8078467.
DOI: 10.1097/MD.0000000000025532.
ACEI/ARB Drug Therapy in COVID-19 Patients: Yes Or No?.
Gong J, Sun Y, Xie L
J Transl Int Med. 2021; 9(1):8-11.
PMID: 33850795
PMC: 8016358.
DOI: 10.2478/jtim-2021-0011.
Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors in COVID-19: Meta-analysis/Meta-regression Adjusted for Confounding Factors.
Lee T, Cau A, Cheng M, Levin A, Lee T, Vinh D
CJC Open. 2021; 3(7):965-975.
PMID: 33842874
PMC: 8023793.
DOI: 10.1016/j.cjco.2021.03.001.
Association Between Renin-Angiotensin-Aldosterone System Inhibitors and Clinical Outcomes in Patients With COVID-19: A Systematic Review and Meta-analysis.
Baral R, Tsampasian V, Debski M, Moran B, Garg P, Clark A
JAMA Netw Open. 2021; 4(3):e213594.
PMID: 33787911
PMC: 8013817.
DOI: 10.1001/jamanetworkopen.2021.3594.
MASPs at the crossroad between the complement and the coagulation cascades - the case for COVID-19.
Bumiller-Bini V, Oliveira-Tore C, Mingorance Carvalho T, Kretzschmar G, Goncalves L, Alencar N
Genet Mol Biol. 2021; 44(1 Suppl 1):e20200199.
PMID: 33729332
PMC: 7982787.
DOI: 10.1590/1678-4685-GMB-2020-0199.
